Literature DB >> 2823181

Acute sensory neuropathy-neuronopathy from pyridoxine overdose.

R L Albin1, J W Albers, H S Greenberg, J B Townsend, R B Lynn, J M Burke, A G Alessi.   

Abstract

We report two patients who developed an acute, profound, and permanent sensory deficit after treatment with massive doses of parenteral pyridoxine. Aside from rapid onset, their clinical picture resembles that described in chronic pyridoxine neurotoxicity. It also is consonant with experimental models of acute pyridoxine intoxication and is probably secondary to a sensory ganglion neuronopathy. These patients also had transient autonomic dysfunction, mild weakness, nystagmus, lethargy, and respiratory depression. These previously undocumented features may be attributable to either the preservative used in the parenteral pyridoxine preparation or to the exceptionally high doses of pyridoxine these patients received.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823181     DOI: 10.1212/wnl.37.11.1729

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Pyridoxine toxicity courtesy of your local health food store.

Authors:  C D Silva; D P D'Cruz
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 2.  Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.

Authors:  Florence van Hunsel; Sonja van de Koppel; Eugène van Puijenbroek; Agnes Kant
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

3.  Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy.

Authors:  M E Helgren; K D Cliffer; K Torrento; C Cavnor; R Curtis; P S DiStefano; S J Wiegand; R M Lindsay
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

4.  Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.

Authors:  TracyAnn Perry; Harold W Holloway; Ananda Weerasuriya; Peter R Mouton; Kara Duffy; Julie A Mattison; Nigel H Greig
Journal:  Exp Neurol       Date:  2006-11-22       Impact factor: 5.330

Review 5.  Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy.

Authors:  Roy Freeman
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

6.  Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats.

Authors:  Michelle C Potter; Krystyna M Wozniak; Noelle Callizot; Barbara S Slusher
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

7.  SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.

Authors:  Joo-Yeon Kang; Dae Young Yoo; Kwon-Young Lee; Wooseok Im; Manho Kim; Jung Hoon Choi; Hwa-Young Youn; Sae Hoon Kim; In Koo Hwang; Jin-Young Chung
Journal:  BMC Neurosci       Date:  2016-01-05       Impact factor: 3.288

Review 8.  Vitamin B6: a long known compound of surprising complexity.

Authors:  Sutton Mooney; Jan-Erik Leuendorf; Christopher Hendrickson; Hanjo Hellmann
Journal:  Molecules       Date:  2009-01-12       Impact factor: 4.411

Review 9.  Vitamin B6: a molecule for human health?

Authors:  Hanjo Hellmann; Sutton Mooney
Journal:  Molecules       Date:  2010-01-20       Impact factor: 4.411

10.  Does pyridoxine control behavioral symptoms in adult patients treated with levetiracetam? Case series from UAE.

Authors:  Taoufik Alsaadi; Khadija El Hammasi; Tarek M Shahrour
Journal:  Epilepsy Behav Case Rep       Date:  2015-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.